Antagonists of gonadotropin releasing hormone

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6150352
SERIAL NO

09180662

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

There are disclosed compounds of formula (I) ##STR1## and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related conditions in both men and women.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
MERCK & CO., INC.RAHWAY, NJ75

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Allen, Eric E Somerset, NJ 19 288
Devita, Robert J Westfield, NJ 43 381
Goulet, Mark Westfield, NJ 32 686
Jiang, Jinlong Wodbridge, NJ 31 168
Toupence, Richard B Scotch Plains, NJ 17 343
Ujjainwalla, Feroze Edison, NJ 42 183
Walsh, Thomas F Watchung, NJ 73 928
Wyvratt, Jr Matthew J Mountainside, NJ 25 328
Young, Jonathan R Dayton, NJ 44 189

Cited Art Landscape

Patent Info (Count) # Cites Year
 
MERCK SHARP & DOHME LTD. (3)
* 5252584 Hydroxyquinolone derivatives 18 1991
* 5348962 Hydroxyquinolone derivatives compounds which have pharmaceutical utility 11 1993
* 5614532 Quinolone derivatives 15 1994
 
SCHERING CORPORATION (2)
* 5175151 Antiviral compounds and antihypertensive compounds 45 1992
* 5412104 Ester and alkoxy substituted benzopyrans 35 1993
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
PFIZER PRODUCTS INC. (1)
6756385 Imidazole derivatives 5 2001
 
NOVO NORDISK A/S (12)
8119159 Solid oral dosage form containing an enhancer 49 2006
* 2007/0196,464 Solid oral dosage form containing an enhancer 21 2006
8323689 Solid oral dosage form containing an enhancer 41 2008
8999383 Compositions of GnRH related compounds and processes of preparation 1 2009
8883201 Solid oral dosage form containing an enhancer 34 2009
8053429 Solid oral dosage form containing an enhancer 50 2009
8883203 Solid oral dosage form containing an enhancer 35 2010
8323690 Solid oral dosage form containing an enhancer 41 2010
* 2010/0209,499 Solid Oral Dosage Form Containing an Enhancer 4 2010
9089484 Pharmaceutical compositions of selective factor Xa inhibitors for oral administration 0 2011
8802114 Pharmaceutical compositions of iron for oral administration 0 2012
8828431 Solid oral dosage form containing an enhancer 36 2012
 
INFINITY PHARMACEUTICALS, INC. (5)
8785470 Heterocyclic compounds and uses thereof 21 2012
9181221 Chemical compounds, compositions and methods for kinase modulation 15 2013
9481667 Salts and solid forms of isoquinolinones and composition comprising and methods of using the same 2 2014
9546180 Heterocyclic compounds and uses thereof 1 2014
9738644 Chemical compounds, compositions and methods for kinase modulation 0 2015
 
MERRION RESEARCH III LIMITED (1)
* 2007/0148,228 Solid oral dosage form containing an enhancer 35 2006
 
PFIZER INC. (2)
* 2006/0149,066 Imidazole derivatives 0 2006
* 2008/0280,879 SUBSTITUTED HETEROCYCLIC DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS 0 2008
* Cited By Examiner